Menu

  • From Data to Tissue

    Thursday, September 17, 2026
    The national-security regulatory landscape now layers a geopolitical framework onto the data flows, sample logistics, and vendor relationships that make modern clinical research possible. This architecture will not simplify. The DSP’s country-of-concern list may expand, the BIOSECURE Act’s ... read more

  • Upperton Receives MHRA License for Sterile Manufacturing Facility

    Thursday, September 17, 2026
    Upperton has received approval from the U.K. Medicines and Healthcare products Regulatory Agency for a variation to its Manufacturing and Importation Authorisation for Investigational Medicinal Products license covering a new sterile manufacturing facility in Nottingham. read more

  • ProBio, Kun Tuo Partner on Advanced-Therapy Trials in China

    Wednesday, September 16, 2026
    ProBio and Kun Tuo, an IQVIA company, have formed a strategic collaboration to provide development, manufacturing and clinical-operations support for biologics and cell and gene therapies in China. read more

  • Piramal Adds 4.3-MWp Solar Plant at UK Site

    Wednesday, September 16, 2026
    Piramal Pharma Solutions is installing a 4.3-MWp ground-mounted solar power plant at its integrated drug-substance and drug-product facility in Morpeth, United Kingdom. read more

  • We Have More Data Than We Know What to Do With

    Wednesday, September 16, 2026
    Every year brings another round of headlines about pharma “drowning in data.” At this point, that’s less a warning than a permanent weather condition. read more
We're sorry, no matching articles were found. Please select different filter options and try your search again.
We're sorry, no matching articles were found. Please select different filter options and try your search again.